Stamford, CT -- (SBWIRE) -- 12/03/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Biozone Pharmaceuticals Inc (OTCBB:BZNE), Allianz SE (ADR) (OTCMKTS:AZSEY), Nuvilex Inc (OTCMKTS:NVLX), 3D EYE SOLUTIONS, IN (OTCMKTS:TDEY)
Biozone Pharmaceuticals Inc (OTCBB:BZNE) ended lower -5.48% from its previous close of $0.73 and complete the day at $0.690. The total number of shares changed hands during the day was 389,510. After opening at $0.73, the stock hit as high as $0.74. However, it traded between $0.16 and $3.75 over the last twelve months.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained positive 43.75% during the previous three months trade. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally. Its OTC products include hair conditioners and shampoos for treatment of eczema and psoriasis; external analgesics; skin protectants.
Has BZNE Found The Bottom and Ready To Move Up? Find Out Here
Allianz SE (ADR) (OTCMKTS:AZSEY) closed yesterday at $17.29, a -0.92% decrease. Around 69,472 shares were traded, low from an-average trading volume of 198,312 shares. The company is now valued at around $78.35 billion. The stock opened the session at $17.37 and touched its highest price point at $17.41.
AZSEY’s lowest price point for the session stood at $17.29 and its 52 week price range stood at $12.92 - $17.55. Allianz SE primarily provides property and casualty, and life/health insurance products to private and corporate customers worldwide. Its Property-Casualty Insurance segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel insurance products.
Has AZSEY Found The Bottom And Ready To Gain Momentum? Find Out Here
Nuvilex Inc (OTCMKTS:NVLX) moved -0.38 percent lower at $0.132 and traded between $0.13 and $0.14 after opening the day at $0.13. Its performance over the last five days remained 5.58%, which stands at 5.58% for a month. Going back further than one month, 1-year performance after recent close was 259.08%.
The company has a total of 637.24 million outstanding shares and its total market capitalization is $84.43 million. Its beta value stands at -0.34 times and earnings per share was -$0.01. Nuvilex, Inc, a biotechnology and life technology company, develops and markets products to improve the health, condition, and well-being. The company offers Cinnechol, a natural supplement, which helps in maintaining normal cholesterol levels and supports normal cardiovascular function; Cinnergen, a liquid whole food nutritional supplement that provides nutrients to help the body process glucose.
Why Should Investors Buy NVLX After the Recent Fall? Just Go Here and Find Out
3D EYE SOLUTIONS, IN (OTCMKTS:TDEY)’s shares rose, +10.20 percent from its previous close of $0.0049 to close at $0.0054. The stock is up around 800% this year and 500% for the last 12 months. Around 34.58 million shares changed hands yesterday, higher from an-average trading volume of 41.41 million shares. 3D Eye Solutions, Inc. engages in developing, providing, and integrating content conversion service for the 3D stereo and auto-stereo media industry in the United States. The company offers 3D Eye Solutions conversion technology that supports education by converting older DVD video content libraries to deliver content for use.
Why Should Investors Buy TDEY After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)